UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

223-OR: Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types

Journal of clinical medicine, 2023-03, Vol.12 (5), p.2049

Fessel, Jeffrey

2023

Volltextzugriff (PDF)

Determination of pioglitazone, its metabolite and alogliptin in human plasma by a novel LC-MS/MS method; application to a pharmacokinetic study

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-11, Vol.1132, p.121803-121803, Article 121803

2019

Volltextzugriff (PDF)

Rapid and Stable Liquid Chromatographic Tandem Mass Spectrometric Method for Simultaneous Estimation of Pioglitazone, Keto Pioglitazone and Hydroxy Pioglitazone in Human Plasma: Application to Bioequivalence Study

Asian journal of chemistry, 2022-11, Vol.34 (11), p.3006-3014

2022

Volltextzugriff (PDF)

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases

Nanomedicine, 2019-07, Vol.19, p.115-125

2019

Volltextzugriff (PDF)

Liquid chromatography tandem mass spectrometry for the simultaneous determination of metformin and pioglitazone in rat plasma: Application to pharmacokinetic and drug-drug interaction studies

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-08, Vol.1124, p.47-57

2019

Volltextzugriff (PDF)

Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

Digestive and liver disease, 2021-01, Vol.53 (1), p.44-51

2021

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models

Cardiovascular research, 2019-02, Vol.115 (2), p.419-431

2019

Volltextzugriff (PDF)

1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

A pilot dose finding study of pioglitazone in autistic children

Molecular autism, 2018-11, Vol.9 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants

Cancer chemotherapy and pharmacology, 2024-05, Vol.93 (5), p.439-453

2024

Volltextzugriff (PDF)

Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

Diabetic medicine, 2019-09, Vol.36 (9), p.1185-1186

2019

Volltextzugriff (PDF)

Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH

Alimentary pharmacology & therapeutics, 2021-10, Vol.54 (7), p.880-889

2021

Volltextzugriff (PDF)

Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture

Journal of diabetes and its complications, 2024-12, Vol.38 (12), p.108897, Article 108897

2024

Volltextzugriff (PDF)

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes care, 2019-08, Vol.42 (8), p.1481-1488

2019

Volltextzugriff (PDF)

A pioglitazon újrafelfedezése

Orvosi hetilap, 2023-07, Vol.164 (26), p.1012-1019

2023

Volltextzugriff (PDF)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial

PloS one, 2018-10, Vol.13 (10), p.e0206722-e0206722

2018

Volltextzugriff (PDF)

Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity

Nature communications, 2020-04, Vol.11 (1), p.2024-2024, Article 2024

2020

Volltextzugriff (PDF)

Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS

Chemical research in toxicology, 2024-05, Vol.37 (5), p.779-790

2024

Volltextzugriff (PDF)

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Diabetologia, 2015-03, Vol.58 (3), p.493-504

2015

Volltextzugriff (PDF)

High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection

Neurotherapeutics, 2022-10, Vol.19 (6), p.1976-1991

2022

Volltextzugriff (PDF)

Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone

Journal of medicinal chemistry, 2019-02, Vol.62 (4), p.2008-2023

2019

Volltextzugriff (PDF)

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

Circulation (New York, N.Y.), 2018-09, Vol.138 (12), p.1210-1220

2018

Volltextzugriff (PDF)

A novel approach to repositioning memantine for metabolic syndrome-induced steatohepatitis: Modulation of hepatic autophagy, inflammation, and fibrosis

Life sciences (1973), 2023-04, Vol.319, p.121509-121509, Article 121509

2023

Volltextzugriff (PDF)

Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis

American journal of physiology: endocrinology and metabolism, 2018-08, Vol.315 (2), p.E163-E173

2018

Volltextzugriff (PDF)

1 – 25 von 4.044

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.543)
Mit Volltextzugriff
(3.473)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Pioglitazone
(3.744)
Science & Technology
(3.207)
Life Sciences & Biomedicine
(2.959)
Humans
(1.734)
Male
(1.365)
Animals
(1.214)
Diabetes
(995)
Female
(931)
Hypoglycemic Agents - Therapeutic Use
(861)
Diabetes Mellitus, Type 2 - Drug Therapy
(820)
Thiazolidinediones - Therapeutic Use
(819)
Pharmacology & Pharmacy
(787)
Insulin Resistance
(775)
Diabetes Mellitus
(758)
Endocrinology & Metabolism
(744)
Thiazolidinediones - Pharmacology
(715)
Middle Aged
(641)
Thiazolidinediones
(596)
Hypoglycemic Agents - Pharmacology
(562)
Rats
(549)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

223-OR: Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence

Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types

Determination of pioglitazone, its metabolite and alogliptin in human plasma by a novel LC-MS/MS method; application to a pharmacokinetic study

Rapid and Stable Liquid Chromatographic Tandem Mass Spectrometric Method for Simultaneous Estimation of Pioglitazone, Keto Pioglitazone and Hydroxy Pioglitazone in Human Plasma: Application to Bioequivalence Study

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases

Liquid chromatography tandem mass spectrometry for the simultaneous determination of metformin and pioglitazone in rat plasma: Application to pharmacokinetic and drug-drug interaction studies

Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models

1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial

A pilot dose finding study of pioglitazone in autistic children

Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants

Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH

Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

A pioglitazon újrafelfedezése

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial

Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity

Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection

Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

A novel approach to repositioning memantine for metabolic syndrome-induced steatohepatitis: Modulation of hepatic autophagy, inflammation, and fibrosis

Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis

Suchergebnisse filtern